When it comes to attracting mega-donors, Republicans are crushing Democrats. By Theodore Schleifer There are many signs that ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

Government programs may soon change how they approach a growing public health challenge that affects millions of Americans each year.

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

The Trump administration is considering a shift in health care coverage, allowing Medicare and Medicaid to cover GLP-1 weight loss drugs.

Leadership at the Centers for Medicare and Medicaid Services is working with states to develop plans to use the $50 billion ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Dr. Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services, discusses the Trump administration’s efforts ...

AtlantiCare Chief Information Officer Jordan Ruch attended a White House summit with tech and healthcare leaders, joining ...

President Trump holds a "Making Health Technology Great" event at the White House with HHS Sec. Robert F. Kennedy Jr. and Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services.